1. From the Department of Pathology and Experimental Therapeutics, University of Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain
2. Biomedical Network Research Center on Neurodegenerative Diseases (CIBERNED), Institute Carlos III, L’Hospitalet de Llobregat, Barcelona, Spain
3. Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain
4. Institute of Neurosciences, University of Barcelona, Barcelona, Spain
5. Neuropathology, Pathologic Anatomy Service, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain
6. Functional Unit of Amyotrophic Lateral Sclerosis (UFELA), Service of Neurology, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain
7. International Initiative for Treatment and Research Initiative to Cure ALS (TRICALS), Utrecht, The Netherlands